Chemoresistance of Plasmodium falciparum and Plasmodium vivax parasites in Brazil: consequences on disease morbidity and control

dc.creatorGama, Bianca Ervatti
dc.creatorLacwrda, Marcus Vinicius Guimarães
dc.creatorDaniel-Ribeiro, Cláudio Tadeu
dc.creatorCruz, Maria de Fátima Ferreira da
dc.date2018-04-17T16:21:21Z
dc.date2018-04-17T16:21:21Z
dc.date2011
dc.date.accessioned2023-09-26T22:34:55Z
dc.date.available2023-09-26T22:34:55Z
dc.identifierGAMA, Bianca E. et al. Chemoresistance of Plasmodium falciparum and Plasmodium vivax parasites in Brazil: consequences on disease morbidity and control. Mem Inst Oswaldo Cruz, v.106, Suppl. I, p.159-166, 2011.
dc.identifier0074-0276
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/25908
dc.identifier1678-8060
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8880635
dc.descriptionIn Brazil, malaria still remains a clinically important febrile syndrome for local populations and travelers, occurring mostly in the Amazon Basin. This review aims to report the main efforts employed to control this disease since the 1940s and the emergence of Plasmodium falciparum and Plasmodium vivax chemoresistance to chloroquine and sulphadoxine-pyrimethamine among other drugs. Additionally, in vivo, in vitro and molecular studies as well as malaria chemoresistance consequences on disease morbidity and policy treatment guidelines were commented.
dc.formatapplication/pdf
dc.languageeng
dc.publisherFundação Oswaldo Cruz. Instituto Oswaldo Cruz
dc.rightsopen access
dc.subjectPlasmodium falciparum
dc.subjectPlasmodium vivax
dc.subjectmalária
dc.subjectBrasil
dc.subjectquimiorresistência
dc.subjectPlasmodium falciparum
dc.subjectPlasmodium vivax
dc.subjectmalaria
dc.subjectchemoresistance
dc.subjectBrazil
dc.titleChemoresistance of Plasmodium falciparum and Plasmodium vivax parasites in Brazil: consequences on disease morbidity and control
dc.typeArticle


Este ítem pertenece a la siguiente institución